B6.129P2-Lcn2tm1Mak/Cnbc

Status

Available to order

EMMA IDEM:06368
International strain nameB6.129P2-Lcn2tm1Mak/Cnbc
Alternative nameLcn 2 C57Bl 6
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolLcn2tm1Mak
Gene/Transgene symbolLcn2

Information from provider

ProviderTak W Mak
Provider affiliationMak Lab, Campbell Family Breast Cancer reseach Institute
Genetic informationLipocalin 2, Targeted (knock-out), Insertion, Intragenic deletion
Phenotypic informationIron-trafficking protein involved in multiple processes such as innate immunity and cancer development. Binds iron through association with 2,5-dihydroxybenzoic acid (2,5-DHBA), a siderophore that shares structural similarities with bacterial enterobactin, and delivers or removes iron from the cell, depending on the context.
Breeding historyPure C57BL/6, backcrossed 10 times.
References
  • Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury.;Berger Thorsten, Togawa Atsushi, Duncan Gordon S, Elia Andrew J, You-Ten Annick, Wakeham Andrew, Fong Hannah E H, Cheung Carol C, Mak Tak W, ;2006;Proceedings of the National Academy of Sciences of the United States of America;103;1834-9; 16446425
  • Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.;Berger Thorsten, Cheung Carol C, Elia Andrew J, Mak Tak W, ;2010;Proceedings of the National Academy of Sciences of the United States of America;107;2995-3000; 20133630
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivinghomozygous 0

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased urine microalbumin level / IMPC
  • decreased thigmotaxis / IMPC
  • decreased circulating serum albumin level / IMPC
  • decreased circulating iron level / IMPC
  • decreased circulating glucose level / IMPC
  • increased heart weight / IMPC
  • increased mean corpuscular volume / IMPC
MGI phenotypes (allele matching)
  • reduced female fertility / MGI
  • increased susceptibility to bacterial infection / MGI
  • renal/urinary system phenotype / MGI
MGI phenotypes (gene matching)
  • increased brown adipose tissue amount / MGI
  • increased white adipose tissue amount / MGI
  • increased circulating LDL cholesterol level / MGI
  • increased leukocyte cell number / MGI
  • increased neutrophil cell number / MGI
  • increased monocyte cell number / MGI
  • abnormal erythropoiesis / MGI
  • increased bone marrow cell number / MGI
  • spleen hyperplasia / MGI
  • thymus hyperplasia / MGI
  • abnormal myelopoiesis / MGI
  • reduced female fertility / MGI
  • increased circulating insulin level / MGI
  • increased susceptibility to bacterial infection / MGI
  • abnormal mast cell physiology / MGI
  • increased hematocrit / MGI
  • hepatic steatosis / MGI
  • increased heart weight / MGI
  • increased liver weight / MGI
  • no phenotypic analysis / MGI
  • increased erythrocyte cell number / MGI
  • increased erythroid progenitor cell number / MGI
  • thrombocytopenia / MGI
  • increased kidney weight / MGI
  • decreased adiponectin level / MGI
  • increased spleen weight / MGI
  • increased lymphocyte cell number / MGI
  • increased B cell number / MGI
  • sepsis / MGI
  • increased circulating cholesterol level / MGI
  • impaired glucose tolerance / MGI
  • insulin resistance / MGI
  • renal/urinary system phenotype / MGI
  • hematopoietic system phenotype / MGI
  • increased macrophage cell number / MGI
  • increased mean corpuscular hemoglobin / MGI
  • increased susceptibility to diet-induced obesity / MGI
  • decreased apoptosis / MGI
  • increased fat cell size / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • increased splenocyte number / MGI
  • increased liver triglyceride level / MGI
  • decreased thymocyte apoptosis / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • myeloid hyperplasia / MGI
  • impaired adaptive thermogenesis / MGI
  • increased erythroblast number / MGI
  • increased fasted circulating glucose level / MGI

Literature references

  • Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury.;Berger Thorsten, Togawa Atsushi, Duncan Gordon S, Elia Andrew J, You-Ten Annick, Wakeham Andrew, Fong Hannah E H, Cheung Carol C, Mak Tak W, ;2006;Proceedings of the National Academy of Sciences of the United States of America;103;1834-9; 16446425
  • Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.;Berger Thorsten, Cheung Carol C, Elia Andrew J, Mak Tak W, ;2010;Proceedings of the National Academy of Sciences of the United States of America;107;2995-3000; 20133630

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).